Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex.

Generation of 15 monoclonal antibodies (MAbs) allowed construction of epitope maps and specific two-site immunofluorometric assays for free prostate-specific antigen (PSA) and PSA complexed with alpha 1-antichymotrypsin (ACT). Close correlation of PSA concentrations obtained with the use of different assays of free PSA suggested extensive similarity in immunodetection of free PSA in serum. Assays of the PSA-ACT complex overestimated the concentration of PSA-ACT in serum because of nonspecific adsorbance of ACT or cathepsin G-complexed ACT to the solid phase. This interference was substantially decreased in the presence of heparin. In studying the stability of purified PSA and PSA-ACT complexes formed in vitro, we found that the free PSA was stable during storage for 4 weeks at 35 degrees C, whereas PSA-ACT complexes largely dissociated in these conditions. The instability of PSA-ACT complexes was counteracted by storage at low temperatures, by adjusting the pH of the storage buffer between 6.8 and 7.4, and through addition of 100-1000-fold molar excess of native ACT. The ease of calibration and the accuracy of free PSA assays in comparison with assays of the PSA-ACT complex suggest that measurements of free to total PSA most accurately reflect the inverse of the proportion of PSA complexed to ACT in serum.

[1]  Emil A. Tanagho,et al.  Smith's General Urology , 1996 .

[2]  H. Lilja,et al.  Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum. , 1995, Clinical chemistry.

[3]  C. Croce,et al.  Expression of the prostate-specific antigen gene by a primary ovarian carcinoma. , 1995, Cancer research.

[4]  E. Diamandis,et al.  Oral Contraceptive-induced Expression of Prostate-specific Antigen in the Female Breast (*) , 1995, The Journal of Biological Chemistry.

[5]  E. Diamandis,et al.  Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. , 1995, The Journal of urology.

[6]  E. Diamandis,et al.  Prostate-specific antigen immunoreactivity in amniotic fluid. , 1995, Clinical chemistry.

[7]  T. Stamey,et al.  Standardization of immunoassays for prostate specific antigen. A different view based on experimental observations , 1994, Cancer.

[8]  E. Diamandis,et al.  Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. , 1994, Clinical biochemistry.

[9]  J. Clements.  The human kallikrein gene family: a diversity of expression and function , 1994, Molecular and Cellular Endocrinology.

[10]  H. Lilja,et al.  Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. , 1994, European journal of biochemistry.

[11]  J. Oesterling,et al.  Influence of patient age on the serum PSA concentration. An important clinical observation. , 1993, The Urologic clinics of North America.

[12]  U. Stenman,et al.  Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with alpha 1-antichymotrypsin. , 1993, Clinical chemistry.

[13]  O. Nilsson,et al.  Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. , 1993, The Journal of urology.

[14]  K. Havemann,et al.  Assay of complexed alpha 1-antichymotrypsin in plasma. , 1993, Clinical chemistry.

[15]  D. Chan,et al.  Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. , 1992, Cancer research.

[16]  M. Benson,et al.  The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. , 1992, The Journal of urology.

[17]  S. Bussen.  Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate , 1992 .

[18]  O. Nilsson,et al.  Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. , 1991, Clinical chemistry.

[19]  J. Oesterling,et al.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. , 1991, The Journal of urology.

[20]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[21]  K. Pettersson,et al.  Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies. , 1991, Clinical chemistry.

[22]  H. Lilja,et al.  Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. , 1990, European journal of biochemistry.

[23]  W. Catalona,et al.  Clinical use of prostate specific antigen in patients with prostate cancer. , 1989, The Journal of urology.

[24]  M. Duffy.  New Cancer Markers , 1989, Annals of clinical biochemistry.

[25]  P. Lange,et al.  Prostate-specific antigen in management of prostatic carcinoma. , 1989, Urology.

[26]  R. Gittes,et al.  Prostate-specific antigen. , 1987, The New England journal of medicine.

[27]  T. Stamey,et al.  Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .

[28]  H. Lilja,et al.  Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. , 1987, The Journal of clinical investigation.

[29]  E. Bertoft,et al.  Determination of hormones by time-resolved fluoroimmunoassay. , 1984, Talanta.

[30]  G. Murphy,et al.  Prostatic‐specific antigen: An immunohistologic marker for prostatic neoplasms , 1981, Cancer.

[31]  G. Murphy,et al.  A prostate antigen in sera of prostatic cancer patients. , 1980, Cancer research.

[32]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[33]  E. Diamandis,et al.  Prostate-specific antigen in milk of lactating women. , 1995, Clinical chemistry.

[34]  Igor Sartori,et al.  Prostate Cancer Screening: What We Know and What We Need to Know: , 1994 .

[35]  Chim Acta,et al.  Assay of Complexed a1 -Antichymotrypsin in Plasma , 1993 .

[36]  U. Stenman,et al.  A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. , 1991, Cancer research.

[37]  A. Böhle,et al.  The Establishment and Evaluation of Luminescent-Labelled Immunometric Assays for Prostate-Speciflc Antigen-α1-Antichymotrypsin Complexes in Serum , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[38]  H. Lilja,et al.  Three predominant proteins secreted by the human prostate gland , 1988, The Prostate.

[39]  G. Murphy,et al.  Prostate antigen: A new potential marker for prostatic cancer , 1981, The Prostate.